Gastrointestinal Diseases in Pregnancy: Nausea, Vomiting, Hyperemesis Gravidarum, Gastroesophageal Reflux Disease, Constipation, and Diarrhea

Gastroenterol Clin North Am. 2016 Jun;45(2):267-83. doi: 10.1016/j.gtc.2016.02.005.

Abstract

Many disorders of the gastrointestinal tract are common in pregnancy. Elevated levels of progesterone may lead to alterations in gastrointestinal motility which could contribute to nausea, vomiting, and/or GERD. Pregnancy-induced diarrhea may be due to elevated levels prostaglandins. This article reviews the normal physiologic and structural changes associated with pregnancy that could contribute to many of the common gastrointestinal complaints in pregnant patients. Additionally, the appropriate clinical and laboratory evaluations, other pathologic conditions that should be included in the differential, as well as the nonpharmacologic and pharmacologic therapies for each of these conditions is discussed.

Keywords: Constipation; Diarrhea; Gastroesophageal reflux disease (GERD); Hyperemesis gravidarum; Pregnancy; Review; Treatment; Vomiting.

Publication types

  • Review

MeSH terms

  • Antacids / therapeutic use
  • Antiemetics / therapeutic use
  • Constipation / physiopathology
  • Constipation / therapy*
  • Diarrhea / physiopathology
  • Diarrhea / therapy*
  • Diet Therapy
  • Emollients / therapeutic use
  • Female
  • Gastroesophageal Reflux / physiopathology
  • Gastroesophageal Reflux / therapy*
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Hyperemesis Gravidarum / physiopathology
  • Hyperemesis Gravidarum / therapy*
  • Laxatives / therapeutic use
  • Nausea / physiopathology
  • Nausea / therapy
  • Parasympatholytics / therapeutic use
  • Pregnancy
  • Pregnancy Complications / physiopathology
  • Pregnancy Complications / therapy*
  • Proton Pump Inhibitors / therapeutic use
  • Vomiting / physiopathology
  • Vomiting / therapy

Substances

  • Antacids
  • Antiemetics
  • Emollients
  • Histamine H2 Antagonists
  • Laxatives
  • Parasympatholytics
  • Proton Pump Inhibitors